Authorship in Academic Literature

口译(哲学) 模棱两可 多学科方法 包裹体(矿物) 医学 冲击系数 梅德林 图书馆学 认识论 社会学 社会科学 计算机科学 法学 政治学 哲学 程序设计语言
作者
Jaime A. Teixeira da Silva
出处
期刊:Clinical pharmacology in drug development [Wiley]
卷期号:12 (4): 457-458 被引量:2
标识
DOI:10.1002/cpdd.1234
摘要

CPDD has transparently outlined authorship-related policies in place for validating authorship.1 In that editorial comment, David J. Greenblatt portrays an insightful historical perspective of authorship in the pharmacological and physiological sciences, showing, using MEDLINE/PubMed data, how the number of authors per paper has increased from about 1.5 in the 1950s to about 6 in 2020.1 Another journal (American Journal of Orthodontics and Dentofacial Orthopedics) also recorded a historical increase in the number of authors per paper, noting that between 1956 and 1965, 87% of papers had only 1 author (4% had >3 authors), but in 1966–2015, <5% of papers were authored by a single author.2 Marder (2022) also noted that until the 1960s, derivative works of PhDs usually only carried the PhD student's name, to reflect a personal endeavor, whereas PhD-derived studies post-1970s tended to also include—at minimum—the PhD supervisor as well.3 Who is a valid author, and is there a limit to the number of authors? There are complexities associated with ascertaining the validity of authorship in multiple-author papers, especially in the light of increasingly complex multidisciplinary and “big data” research, so the intellectual significance of individual authors is a key factor.4 Conversely, the failure to attribute authorship to valid intellectual contributors is unethical,4 while sudden requests to change authorship (adding, removing, indicating nonpermitted inclusion, or exclusion) can be challenging for journal editors to detect and manage.5 Ambiguity and discord often arise because there is subjective interpretation surrounding what constitutes a “substantial contribution.”6 It is also complex to ascertain the validity of authorship from a deontological perspective because different forms of contribution may be incommensurable while the determination of responsibility is intangible.7 What should the order of authors be? CPDD does not control the order of authors and has in place a 1-corresponding-author–1-paper rule.1 As in CPDD,1 a common authorship-related editorial policy in biomedical journals is to leave the choice of decision regarding the order of authorship in the hands of authors.8 In such instances, a document that offers a rationale for that order is rarely if ever submitted. However, when reliable verification steps or documents are missing, this may open up the possibility of authorship abuse because the signal sent is that regulation is lax. In guest authorship, guest authors might be offered a senior (last author) position, or they might be assigned a guest co-corresponding author status.9 What tools are available to assist editors in the verification of an author's identification? Open Researcher and Contributor ID (ORCID) is currently likely the most widely adopted author identification persistent identifier. CPDD does not have a mandatory ORCID policy for submissions.1 Despite the documented strengths of ORCID such as author disambiguation,10 it is not always able to disambiguate fake from real authors, especially if there is insufficient background metadata in ORCID accounts of authors with identical names. Unfortunately, ORCID has been abused by providing a form of support or authorship “validation” tool for authors associated with “paper mills.”11 Another mechanism to hold authors accountable for their contributions in academic papers is CRediT (Contributor Roles Taxonomy),12 but since statements that define the roles of each author are controlled by authors themselves, there is no way that editors or reviewers can independently or accurately verify the veracity of those statements. In the author's opinion, there are thus insufficiently robust tools currently available to determine, with absolute certainty, (1) the valid existence and/or identity of an author or (2) their quantitative or qualitative contribution to an academic paper. Some biomedical journals are making laudable efforts to avoid guest, gift, or ghost authorship,13 but a formidable challenge for the academic community would be to devise robust methods and tools and to develop tangible and verifiable criteria that would be able to assess and confirm the validity of an author's identification and of an author's contribution, that is, to validate authorship. The author declares no conflicts of interest of relevance to this topic.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
深情安青应助认真的裙子采纳,获得10
1秒前
1秒前
搜集达人应助niu1采纳,获得10
1秒前
2秒前
SciGPT应助飞翔鱿鱼采纳,获得10
3秒前
白雪皑皑完成签到,获得积分20
4秒前
4秒前
sgaaufe发布了新的文献求助10
4秒前
Helium发布了新的文献求助10
4秒前
5秒前
啵咛发布了新的文献求助10
5秒前
凯凯完成签到 ,获得积分10
6秒前
圆圆发布了新的文献求助10
7秒前
daidai完成签到,获得积分10
7秒前
8秒前
lily发布了新的文献求助10
9秒前
sgaaufe完成签到,获得积分20
10秒前
看文献也是技术活完成签到,获得积分10
11秒前
Akim应助小可爱采纳,获得10
11秒前
安静笑晴发布了新的文献求助10
11秒前
HalfGumps发布了新的文献求助10
12秒前
心灵美的大山关注了科研通微信公众号
13秒前
13秒前
holmes完成签到 ,获得积分10
14秒前
Helium完成签到,获得积分10
14秒前
gentlescum发布了新的文献求助30
15秒前
15秒前
小李发布了新的文献求助10
16秒前
zhaohuanjun发布了新的文献求助10
19秒前
开心听露发布了新的文献求助10
19秒前
19秒前
Heisenberg发布了新的文献求助10
20秒前
CodeCraft应助碗碗采纳,获得10
20秒前
琪琪琪琪完成签到 ,获得积分10
20秒前
21秒前
Ch发布了新的文献求助10
21秒前
21秒前
汉堡包应助FG采纳,获得10
23秒前
冬霖完成签到 ,获得积分10
24秒前
24秒前
高分求助中
The Oxford Handbook of Social Cognition (Second Edition, 2024) 1050
Kinetics of the Esterification Between 2-[(4-hydroxybutoxy)carbonyl] Benzoic Acid with 1,4-Butanediol: Tetrabutyl Orthotitanate as Catalyst 1000
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
Chen Hansheng: China’s Last Romantic Revolutionary 500
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3141127
求助须知:如何正确求助?哪些是违规求助? 2792031
关于积分的说明 7801479
捐赠科研通 2448267
什么是DOI,文献DOI怎么找? 1302482
科研通“疑难数据库(出版商)”最低求助积分说明 626591
版权声明 601226